Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Kokoh Exa Nusantara Tbk (KOCI) vs Merck Tbk. (MERK) Price & Performance

Kokoh Exa Nusantara TbkTrade
Merck Tbk.Trade

Price performance (Past 24H)

Key statistics

Kokoh Exa Nusantara Tbk vs Merck Tbk. — how do they compare? Kokoh Exa Nusantara Tbk trades at Rp101 (market cap 451.21B, 14.06M 24h volume), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume). The key difference: Merck Tbk. is far larger — about 3.8× Kokoh Exa Nusantara Tbk's market cap, and Kokoh Exa Nusantara Tbk is more actively traded (14.06M versus 37.6K). Which is the better fit depends on your goals.

KOCIMERK
Market Cap
451.21B1.7T
Volume
14.06M37.6K
Lot
140.63K376
Turnover
1.41B144.47M
Average Price
100.563,842.23
Value
1.41B144.47M
Indicative Equilibrium Price
1013,840
Indicative Equilibrium Volume
1.94K7

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

KOCI
View details
MERK
View details

About Kokoh Exa Nusantara Tbk

PT Kokoh Exa Nusantara Tbk (the Entity) was established based on Notarial Deed No. 173, dated July 31, 2019 of Dwi Rossulliati, S.H., notary in Mojokerto Regency. The Entity started its commercial operations in 2020. PT Exa Nusa Persada is its ultimate parent entity.

Read more on KOCI

About Merck Tbk.

PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.

Read more on MERK